A bill was recently introduced in California that would give pharmaceutical companies the opportunity to buy patient information from their pharmacies. This information would involve prescriptions and contact details. The goal of the bill is to allow pharmaceutical companies to send regular mailings of an educational nature that could be extremely beneficial to patients. Many view the proposed legislation as a violation of privacy rights. It failed in a vote by the Health Committee on Wednesday, March 12 and is likely to be voted on for a second time after spring break. Several amendments are anticipated to limit certain aspects of the bill in an attempt to maintain patient privacy.